In the present study, we found that LINC01833 is modulated by METTL3-mediated m6A RNA methylation, suggesting that the METTL3-medicated m6A RNA methylation plays crucial roles in the regulation of LINC01833 on NSCLC progression. The gene discussed is METTL3; the disease is non-small cell lung carcinoma.